Structural basis of norepinephrine recognition and transport inhibition in neurotransmitter transporters.
Analgesics, Opioid
/ chemistry
Animals
Binding Sites
Crystallography, X-Ray
Dopamine
Dopamine Plasma Membrane Transport Proteins
Drosophila Proteins
/ chemistry
Drosophila melanogaster
HEK293 Cells
Humans
Mice, Knockout
Models, Molecular
Neurotransmitter Transport Proteins
/ chemistry
Norepinephrine
/ chemistry
Sf9 Cells
Transcriptome
Journal
Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555
Informations de publication
Date de publication:
13 04 2021
13 04 2021
Historique:
received:
18
08
2020
accepted:
01
03
2021
entrez:
14
4
2021
pubmed:
15
4
2021
medline:
29
4
2021
Statut:
epublish
Résumé
Norepinephrine is a biogenic amine neurotransmitter that has widespread effects on alertness, arousal and pain sensation. Consequently, blockers of norepinephrine uptake have served as vital tools to treat depression and chronic pain. Here, we employ the Drosophila melanogaster dopamine transporter as a surrogate for the norepinephrine transporter and determine X-ray structures of the transporter in its substrate-free and norepinephrine-bound forms. We also report structures of the transporter in complex with inhibitors of chronic pain including duloxetine, milnacipran and a synthetic opioid, tramadol. When compared to dopamine, we observe that norepinephrine binds in a different pose, in the vicinity of subsite C within the primary binding site. Our experiments reveal that this region is the binding site for chronic pain inhibitors and a determinant for norepinephrine-specific reuptake inhibition, thereby providing a paradigm for the design of specific inhibitors for catecholamine neurotransmitter transporters.
Identifiants
pubmed: 33850134
doi: 10.1038/s41467-021-22385-9
pii: 10.1038/s41467-021-22385-9
pmc: PMC8044178
doi:
Substances chimiques
Analgesics, Opioid
0
DAT protein, Drosophila
0
Dopamine Plasma Membrane Transport Proteins
0
Drosophila Proteins
0
Neurotransmitter Transport Proteins
0
Dopamine
VTD58H1Z2X
Norepinephrine
X4W3ENH1CV
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
2199Subventions
Organisme : DBT-Wellcome Trust India Alliance
ID : IA/I/15/2/502063
Pays : India
Organisme : Wellcome Trust
Pays : United Kingdom
Références
Nature. 2015 May 21;521(7552):322-7
pubmed: 25970245
Front Mol Biosci. 2019 Sep 06;6:80
pubmed: 31555663
Nat Struct Mol Biol. 2015 Jun;22(6):506-508
pubmed: 25961798
Proc Natl Acad Sci U S A. 2018 Sep 18;115(38):E8854-E8862
pubmed: 30181291
Nature. 2013 Nov 7;503(7474):141-5
pubmed: 24121440
Nat Commun. 2019 Jun 20;10(1):2714
pubmed: 31221956
Nat Rev Drug Discov. 2004 Aug;3(8):673-83
pubmed: 15286734
Int J Mol Sci. 2016 Jan 26;17(2):
pubmed: 26821017
J Biol Chem. 2012 Nov 16;287(47):39316-26
pubmed: 23007398
Structure. 2013 May 7;21(5):694-705
pubmed: 23664361
Pain Med. 2007 Nov-Dec;8(8):633-8
pubmed: 18028041
Acta Crystallogr D Biol Crystallogr. 2011 Apr;67(Pt 4):235-42
pubmed: 21460441
Pharmacol Ther. 2007 Mar;113(3):523-36
pubmed: 17303246
J Am Chem Soc. 2003 Mar 5;125(9):2770-85
pubmed: 12603166
Nature. 2019 May;569(7754):141-145
pubmed: 31019304
EMBO J. 2021 Jan 4;40(1):e105164
pubmed: 33155685
Proc Natl Acad Sci U S A. 2011 Jul 19;108(29):12137-42
pubmed: 21730142
Nat Struct Mol Biol. 2018 Feb;25(2):170-175
pubmed: 29379174
Chem Commun (Camb). 2009 Jul 7;(25):3677-92
pubmed: 19557250
J Neurosci. 2002 Jan 15;22(2):389-95
pubmed: 11784783
Nat Rev Neurosci. 2009 Mar;10(3):211-23
pubmed: 19190638
Elife. 2019 Oct 17;8:
pubmed: 31621581
Science. 2008 Dec 12;322(5908):1655-61
pubmed: 19074341
Proc Natl Acad Sci U S A. 2009 Apr 7;106(14):5563-8
pubmed: 19307590
Front Synaptic Neurosci. 2016 Aug 26;8:25
pubmed: 27616990
Eur J Pharmacol. 1997 Dec 11;340(2-3):249-58
pubmed: 9537821
Mol Pharmacol. 2001 Jan;59(1):83-95
pubmed: 11125028
Bioorg Med Chem Lett. 2008 Feb 15;18(4):1346-9
pubmed: 18207394
Nat Struct Mol Biol. 2019 Jul;26(7):545-556
pubmed: 31270469
Am J Physiol. 1985 Jul;249(1 Pt 2):H49-56
pubmed: 2861749
Nature. 1996 Feb 15;379(6566):606-12
pubmed: 8628395
Nature. 2013 Nov 7;503(7474):85-90
pubmed: 24037379
Methods Mol Biol. 2008;426:419-35
pubmed: 18542881
Nature. 1991 Nov 7;354(6348):66-70
pubmed: 1944572
Proc Natl Acad Sci U S A. 2011 Sep 20;108(38):15810-5
pubmed: 21885739
Prog Neurobiol. 2006 Oct;80(2):53-83
pubmed: 17030082
Nature. 1964 Dec 26;204:1318-9
pubmed: 14254430
Nature. 1991 Mar 28;350(6316):350-4
pubmed: 2008212
Nat Rev Neurosci. 2003 Jan;4(1):13-25
pubmed: 12511858
ACS Chem Neurosci. 2013 Feb 20;4(2):295-309
pubmed: 23421681
Clin Pharmacokinet. 2004;43(13):879-923
pubmed: 15509185
Nature. 2016 Apr 21;532(7599):334-9
pubmed: 27049939
Acta Crystallogr D Biol Crystallogr. 2015 Mar;71(Pt 3):646-66
pubmed: 25760612
J Biol Chem. 1994 Jun 10;269(23):15985-8
pubmed: 8206893
Sci Rep. 2015 Oct 27;5:15650
pubmed: 26503701
Acta Crystallogr D Biol Crystallogr. 2004 Dec;60(Pt 12 Pt 1):2126-32
pubmed: 15572765
Science. 1991 Oct 25;254(5031):578-9
pubmed: 1948035
Acta Crystallogr D Biol Crystallogr. 2010 Feb;66(Pt 2):125-32
pubmed: 20124692
Nat Commun. 2019 Apr 11;10(1):1687
pubmed: 30976000
J Biol Chem. 2012 Dec 21;287(52):43694-707
pubmed: 23086945
Br J Pharmacol. 2018 Feb;175(3):532-543
pubmed: 29210063
J Med Chem. 2000 May 18;43(10):2064-71
pubmed: 10821718
Nat Struct Mol Biol. 2010 Jul;17(7):822-9
pubmed: 20562855
Nature. 2012 Jan 09;481(7382):469-74
pubmed: 22230955
J Pharmacol Exp Ther. 2016 Apr;357(1):24-35
pubmed: 26813929
J Biol Chem. 2007 Jun 15;282(24):17837-44
pubmed: 17428804
Br J Pharmacol. 2006 Jan;147 Suppl 1:S82-8
pubmed: 16402124
Drugs. 1997;53 Suppl 2:18-24
pubmed: 9190321
Neuron. 2015 Jun 3;86(5):1145-57
pubmed: 26050034
Pharmacol Rev. 2011 Sep;63(3):585-640
pubmed: 21752877
J Neurosci. 2005 Jul 6;25(27):6343-9
pubmed: 16000624
J Appl Crystallogr. 2007 Aug 1;40(Pt 4):658-674
pubmed: 19461840
Nat Protoc. 2014 Nov;9(11):2574-85
pubmed: 25299155
J Pharmacol Exp Ther. 2008 Dec;327(3):982-90
pubmed: 18801947